z-logo
open-access-imgOpen Access
FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts
Author(s) -
Cindy Neuzillet,
Olivia Hentic,
Benoı̂t Rousseau,
Vinciane Rebours,
Léïla Bengrine-Lefèvre,
Franck Bonnetain,
Philippe Lévy,
Éric Raymond,
Philippe Ruszniewski,
Christophe Louvet,
Pascal Hammel
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i33.4533
Subject(s) - irinotecan , folfiri , gemcitabine , medicine , regimen , gastroenterology , fluorouracil , chemotherapy , adenocarcinoma , oncology , surgery , colorectal cancer , cancer
To evaluate the efficacy and safety of the FOLFIRI regimen in patients with metastatic pancreatic adenocarcinoma (PAC) after the failure of gemcitabine and platinum salts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here